Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 801–900 of 1,001
Garza, R. D. L., Fabrizio, K. R., Radoi, G. E., Vlad, T., & Asnis, G. M. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00211-0 · Cited by 35
The HPA axis response to insulin hypoglycemia in depression
López, J. F., Kathol, R. G., Jaeckle, R. S., & Meiler, W. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90226-5 · Cited by 33
Pharmacotherapy of Early-Onset Depression
Martin, A., Kaufman, J., & Charney, D. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30139-1 · Cited by 34
Schuld, A., Schmid, D. A., Haack, M., Holsboer, F., Friess, E., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00054-2 · Cited by 32
“, 1984) and increased levels of corticotropin-releasing hormone (CRH) in cerebrospinal fluid (Nemeroff et al., 1984) have been demonstrated.”
BackgroundCardiology and lifestyle medicine
Rozanski, A., Blumenthal, J. A., Hinderliter, A. L., Cole, S. W., & Lavie, C. J. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.04.004 · Cited by 35
Brain Mapping: The Applications
Mayberg, H. S., & McGinnis, S. M. (2000) · Elsevier eBooks · doi:10.1016/b978-012692545-6/50018-0 · Cited by 32
Lesch, K., Müller, U., Rupprecht, R., Kruse, K., & Schulte, H. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb10308.x · Cited by 32
ACTH in plasma and CSF in the rhesus monkey
Kalin, N. H. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90140-x · Cited by 32
Fahlbusch, R., & Barocka, A. (1995) · Acta Neurochirurgica · doi:10.1007/bf01809343 · Cited by 32
Glucocorticoids as Predictors of Treatment Response in Depression
Horstmann, S., & Binder, E. B. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.586550 · Cited by 34
Edible Mushrooms as a Potential Component of Dietary Interventions for Major Depressive Disorder
Fijałkowska, A., Jędrejko, K., Sułkowska‐Ziaja, K., Ziaja, M., Kała, K., & Muszyńska, B. (2022) · Foods · doi:10.3390/foods11101489 · Cited by 34
“in the cerebrospinal fluid and reduced mRNA expression of the CRH receptor in the frontal cortex have been observed [29,30].”
BackgroundReyes, B. A. S., Bangasser, D. A., Valentino, R. J., & Bockstaele, E. J. V. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.07.017 · Cited by 33
“…would result in increased activation of the LC-arousal system under conditions of CRF hypersecretion, as are thought to occur in depression and post-traumatic stress disorder (Nemeroff et al. 1984; Kaye et al. 1987; Raadsheer et al. 1994; Checkley 1996; Bremner et al. 1997; Baker et al. 1999).”
BackgroundBryce, C. A., & Floresco, S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05244-w · Cited by 31
Friedmann, E., Son, H., & Saleem, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801292-5.00007-9 · Cited by 37
Jagoda, E. M., Contoreggi, C. S., Lee, M.-J., Kao, C. K., Szajek, L. P., LISTWAK, S. J., Gold, P. W., Chrousos, G. P., Greiner, E., Kim, B. M., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034077k · Cited by 31
Austin, M. C., Rice, P. M., Mann, J. J., & Arango, V. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00420-a · Cited by 35
Rupprecht, R., & Lesch, K. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258628 · Cited by 31
HPA axis function in depression and dementia: A review
O'Brien, J. T., Ames, D. J., & Schweitzer, I. (1993) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930081103 · Cited by 33
“The possibility of CRH hypersecretion is supported by the finding of increased CRH levels in the cerebral spinal fluid (CSF) of depressed patients in most (Nemeroff et al., 1984; Banki et al., 1992), though not all (Roy et al., 1987) studies.”
BackgroundAmsterdam, J. D., Maislin, G., Berwish, N., Phillips, J. J., & Winokur, A. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810060072011 · Cited by 33
CRHR1 Antagonists as Novel Treatment Strategies
Holsboer, F. (2001) · CNS Spectrums · doi:10.1017/s1092852900002133 · Cited by 30
Childhood sexual abuse and preterm labor in adulthood: an endocrinological hypothesis
Horan, D. L., Hill, L. D., & Schulkin, J. A. (2000) · Women s Health Issues · doi:10.1016/s1049-3867(99)00038-9 · Cited by 34
Heinzmann, J.-M., Kloiber, S. M., Mattos, G. E., Bielohuby, M., Schmidt, M. V., Palme, R., Holsboer, F., Uhr, M., Ising, M., & Touma, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.008 · Cited by 32
Rudorfer, M. V., Risby, E. D., Osman, O. T., Gold, P. W., & Potter, W. Z. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)91287-2 · Cited by 30
Ehnvall, A., Sjögren, M. J. C., Zachrisson, O., & �gren, H. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0512-3 · Cited by 32
“Some studies have reported elevations of CRH concentration in the CSF of depressed patients (Banki et al. 1987; Nemeroff et al. 1984).”
BackgroundAggressive behavior: Implications of dominance and subordination for the study of mental disorders
Arregi, A., Azpiroz, A., Fano, E., & Garmendia, L. (2006) · Aggression and Violent Behavior · doi:10.1016/j.avb.2006.01.005 · Cited by 32
Scott, L. V., Medbak, S., & Dinan, T. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00232-7 · Cited by 32
Nakase, S., Kitayama, I. T., Soya, H., Hamanaka, K., & Nomura, J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00232-x · Cited by 32
Budziszewska, B. (2002) · PubMed · Cited by 32
CORTICOTROPIN-RELEASING FACTOR IN PLASMA OF DEPRESSED PATIENTS AND CONTROLS
Charlton, B. G., Leake, A., Ferrier, I. N., Linton, E. A., & Lowry, P. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92302-0 · Cited by 30
Widerlöv, E., Ekman, R., Jensen, L., Borglund, L., & Nyman, K. (1989) · Journal of Neural Transmission · doi:10.1007/bf01677423 · Cited by 30
Self-citationCSF Neuropeptides in Euthymic Bipolar Patients and Controls
Berrettini, W. H., Nürnberger, J. I., Zerbe, R. L., Gold, P. W., Chrousos, G. P., & Tomai, T. P. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.150.2.208 · Cited by 30
Neuropeptides in human cerebrospinal fluid
Berrettini, W. H., Nürnberger, J. I., Gold, P. W., Chrétien, M., Chrousos, G. P., Chan, J. S. D., Goldin, L. R., & Gershon, E. S. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90139-0 · Cited by 30
Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
“…suggest CRF contributes to anxiety‐type depression and is consistently up‐regulated in CSF of depressed patients (Hartline, Owens, & Nemeroff, 2018; Nemeroff et al., 1984), its precise physiological contribution to depressive symptoms remains elusive because of confounding clinical studies…”
BackgroundGhrelin effects expression of several genes associated with depression-like behavior
Poretti, M. B., Rask‐Andersen, M., Kumar, P., de Barioglio, S. R., de Cúneo, M. F., Schiöth, H. B., & Carlini, V. P. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.09.012 · Cited by 31
“Other than the monoaminergic theories of MDD, the inflammatory hypothesis was formulated, being found a higher proinflammatory cytokines expression in the peripheral blood of patients with MDD (Tsao et al., 2006).”
BackgroundInfluentialIqbal, J., Li, W., Hasan, M., Li, Y. J., Ullah, K., Wang, Y., Awan, M. U. F., Qing, H., & Deng, Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300337 · Cited by 29
van Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 34
“Moreover, CRH concentrations in CSF and in the median eminence are elevated; expression of CRH mRNA in the PVN is increased, while CRH binding in the pituitary is decreased and that in the extrahypothalamic CRH system is increased (Plotsky and Meany, 1993; Ladd et al., 1996; Plotsky et al., 1998; Workel et al., 1997;…”
BackgroundInfluentialAlda, M., Turecki, G., Grof, P., Cavazzoni, P. A., Duffy, A. C., Grof, E., Ahrens, B., Bergh�fer, A., Müller-Oerlinghausen, B., �kov�, M. D., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000403)96:2<178::aid-ajmg11>3.0.co;2-c · Cited by 31
Budziszewska, B., Jaworska-Feil, L., Tetich, M., Basta‐Kaim, A., Kubera, M., Leśkiewicz, M., & Lasoń, W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300379 · Cited by 29
“Moreover, the elevated CRH concentrations in the cerebrospinal fluid of depressed patients and increased number of CRHexpressing neurons in the hypothalamus (Nemeroff et al, 1984; Raadsheer et al, 1994) suggest that the hyperactivity of the HPA axis is a result of hypersecretion of CRH.”
BackgroundRoseboom, P. H., Urben, C. M., & Kalin, N. H. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00162-0 · Cited by 29
Weinstock, M., & Poltyrev, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1577-9 · Cited by 32
“This form of depression is associated with a hyperactive hypothalamic pituitary adrenal (HPA) system (Heim et al. 2000), impaired feedback regulation via glucocorticoid receptors (Holsboer-Trachsler et al. 1991) and increased levels of corticotrophin-releasing hormone (CRH) in the cerebrospinal fluid ( Nemeroff et al.…”
Neurotransmitters and Neuropeptides in Alzheimer's Disease
McDonald, W. M., & Nemeroff, C. B. (1991) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30316-2 · Cited by 31
Self-citationNeurobiological and psychopharmacological basis in the therapy of bulimia and anorexia
Mauri, M. C., Rudelli, R., Somaschini, E., Roncoroni, L., Papa, R. E., Mantero, M., Longhini, M., & Penati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00306-1 · Cited by 33
Changes of CSF neuropeptides after environmental stimulation in dementia
Karlsson, I., Widerlöv, E., Melin, E., Nyth, A. L., Bråne, G., Rybo, E., Rehfeld, J. F., Bissette, G., & Nemeroff, C. B. (1985) · Nordic Journal of Psychiatry · doi:10.3109/08039488509101961 · Cited by 29
Self-citationKurata, A., Morinobu, S., Fuchikami, M., Yamamoto, S., & Yamawaki, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.03.016 · Cited by 28
de la Tremblaye, P. B., & Plamondon, H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.07.001 · Cited by 28
“Patients suffering from major depression show elevated cerebrospinal fluid (CSF) CRH concentrations (Hartline et al., 1996; Heuser et al., 1998; Nemeroff et al., 1984) and increased numbers of both CRH-secreting neurons and CRH neurons that co-express arginine vasopressin (AVP) mRNA in the…”
BackgroundAssociation of PDE11A global haplotype with major depression and antidepressant drug response
Wong, M. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4771 · Cited by 32
“corticotropin-releasing hormone (CRH) neurons and elevated cortisol levels are associated with major depression.(23,24) It is well known that Cushing syndrome(25) may be caused by increased levels of cortisol resulting from adrenocorticotropic hormone (ACTH)-producing pituitary tumors that are resistant to glucocortic…”
Wang, L., Sun, Y., Zhao, T., Li, Y., Zhao, X., Zhang, L., Wu, L., Zhang, L., Zhang, T., Wei, G., et al. (2019) · Planta Medica · doi:10.1055/a-1068-9686 · Cited by 30
“has been shown to be hypersecreted in patients with depression [20].”
BackgroundLozovaya, N., & Miller, A. D. (2003) · ChemBioChem · doi:10.1002/cbic.200200492 · Cited by 26
Hamke, M., Herpfer, I., Lieb, K., Wandelt, C., & Fiebich, B. L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.026 · Cited by 30
Circadian rhythm of urinary steroid metabolites
Jerjes, W. K., Cleare, A. J., Peters, T. J., & Taylor, N. (2006) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306777695564 · Cited by 28
Fadda, P., Pani, L., Porcella, A., & Fratta, W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11612-z · Cited by 30
Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons
Curtis, A. L., & Valentino, R. J. (1991) · Psychopharmacology · doi:10.1007/bf02244286 · Cited by 30
Immune-endocrine host response to endotoxin in major depression
Vedder, H., Schreiber, W., Schuld, A., Kainz, M., Lauer, C. J., Krieg, J.-C., Holsboer, F., & Pollmächer, T. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.014 · Cited by 27
Raper, J., Stephens, S. B. Z., Henry, A. R., Villareal, T., Bachevalier, J., Wallen, K., & Sánchez, M. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0269-14.2014 · Cited by 28
“Early life stress, including adverse caregiving experiences, leads to alterations in HPA axis function (Nemeroff et al., 1984; Sanchez, 2006; Hostinar and Gunnar, 2013).”
BackgroundCardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers
Wood, S. K. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00950 · Cited by 29
“Combat-exposed individuals with PTSD also have significantly lower levels of NPY in CSF (Rasmusson et al., 2000; Sah et al., 2014) and NPY levels recover following remission (Yehuda et al., 2006).”
BackgroundInfluentialXenobiotics and the Glucocorticoid Receptor
Gulliver, L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.02.003 · Cited by 28
Hajjar, R. R., Kamel, H. K., & Denson, K. M. (2004) · The Internet Journal of Geriatrics and Gerontology · doi:10.5580/765 · Cited by 40
Katagiri, H., Kagaya, A., Nakae, S., Morinobu, S., & Yamawaki, S. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00179-8 · Cited by 28
Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain
Perez‐Nievas, B. G., Madrigal, J. L. M., García‐Bueno, B., Zoppi, S., & Leza, J. C. (2009) · Brain Research · doi:10.1016/j.brainres.2009.12.014 · Cited by 29
Saxena, B., & Sanjay, S. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70705-8 · Cited by 32
Wied, C. C. G., Westenberg, H. G. M., Koppeschaar, H. P. F., Thijssen, J. H. H., & van Ree, J. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90003-q · Cited by 27
Sex differences in the ACTH response to 24H metyrapone in depression
Young, E. A., & Ribeiro, S. C. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.05.053 · Cited by 28
Yogic exercises and health--a psycho-neuro immunological approach.
Kulkarni, D. D., & Bera, T. K. (2009) · PubMed · Cited by 30
Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients
Schuld, A., Kraus, T., Haack, M., Hinze‐Selch, D., Zobel, A. W., Holsboer, F., & Pollmächer, T. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00039-1 · Cited by 31
Response of ACTH and Cortisol to Corticotropin-Releasing Hormone in Anorexia Nervosa
Cavagnini, F., Invitti, C., Passamonti, M., & Polli, E. E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140318 · Cited by 27
Corticotropin-releasing factor mediated muscle atonia in pons and medulla
Lai, Y.-Y., & Siegel, J. M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90423-7 · Cited by 27
Controversies about a common etiology for eating and mood disorders
Rossetti, C., Halfon, O., & Boutrel, B. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01205 · Cited by 30
Acyloxyacyl hydrolase modulates depressive-like behaviors through aryl hydrocarbon receptor
Aguiniga, L. M., Yang, W., Yaggie, R. E., Schaeffer, A. J., & Klumpp, D. J. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00029.2019 · Cited by 28
Ehnvall, A., Sjögren, M., Zachrisson, O., & Ågren, H. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00011-3 · Cited by 26
Expression Profiling Identifies the CRH/CRH-R1 System as a Modulator of Neurovascular Gene Activity
Deussing, J. M., Kühne, C., Pütz, B., Panhuysen, M., Breu, J., Stenzel‐Poore, M. P., Holsboer, F., & Wurst, W. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600451 · Cited by 28
“Hypersecretion of CRH from the paraventricular nucleus of the hypothalamus accounting for HPA axis hyperactivity as well as elevated CRH levels detectable in the cerebrospinal fluid are prominent findings in patients with major depression (Nemeroff et al, 1984).”
BackgroundDepression and Osteoporosis in Men: Association or Casual Link?
Ilias, Ι., Alesci, S., Gold, P. W., & Chrousos, G. P. (2006) · HORMONES · doi:10.14310/horm.2002.11164 · Cited by 29
Neuropeptides and Alzheimer's disease
Gottfries, C., Frederiksen, S. O., & Heilig, M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)80009-q · Cited by 27
Function of the adrenal cortex in patients with major depression
Kalin, N. H., Dawson, G., Tariot, P. N., Shelton, S. E., Barksdale, C. M., Weiler, S. J., & Thienemann, M. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90099-0 · Cited by 27
Biochemical Studies in Suicide Victims: Current Findings and Future Implications
Stanley, M., & Stanley, B. (1989) · Suicide and Life-Threatening Behavior · doi:10.1111/j.1943-278x.1989.tb00364.x · Cited by 27
Basta‐Kaim, A., Budziszewska, B., Jaworska-Feil, L., Tetich, M., Kubera, M., Leśkiewicz, M., & Lasoń, W. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.008 · Cited by 28
PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density?
Sullivan, G. M., Parsey, R. V., Kumar, J. S. D., Arango, V., Kassir, S. A., Huang, Y.-Y., Simpson, N. R., Heertum, R. L. V., & Mann, J. J. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.01.012 · Cited by 26
Brain corticotropin-releasing hormone receptors on neurons and astrocytes
Kapcala, L. P., & Dicke, J. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)91174-d · Cited by 26
Hsin, L., WEBSTER, E. L., Chrousos, G. P., Gold, P. W., Eckelman, W. C., Contoreggi, C. S., & Rice, K. C. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00071-8 · Cited by 25
Antagonists of the Corticotropin Releasing Factor Receptor
Saunders, J., & Williams, J. (2003) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(02)41006-5 · Cited by 25
Brady, L. S., Lynn, A. B., Glowa, J. R., Le, D. Q., & Herkenham, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117444 · Cited by 25
“Wesuggested that the CRHeffect is relevant to the therapeutic efficacy of antidepressant drugs in depression because (a) the temporal aspects of the effect agree with the delayed onset of therapeutic efficacy, and (b) the direction of the effect is opposite and may therefore counteract the hypersecretion of CRHfound i…”
BackgroundAn evaluation of the role of the noradrenergic system in the neurobiology of depression: a review
Redmond, A., & Leonard, B. E. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199709/10)12:5<407::aid-hup918>3.0.co;2-1 · Cited by 26
Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System
Ronan, P. J., & Summers, C. H. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00006-5 · Cited by 28
Minireview: CRF and Wylie Vale: A Story of 41 Amino Acids and a Texan with Grit
Bale, T. L., & Chen, A. (2012) · Endocrinology · doi:10.1210/en.2012-1273 · Cited by 23
“In fact, it was during this time that clinical studies investigating stress dysregulation in mental health disorders discovered elevated CRF levels in the CSF of depressed patients, launching a new era focusing drug targets in pharmaceutical treatment of affective disorders and other stress-related diseases (11, 12).”
Cortagine: Behavioral and Autonomic Function of the Selective CRF Receptor Subtype 1 Agonist
Farrokhi, C. B., Tovote, P., Blanchard, R. J., Blanchard, D. C., Litvin, Y., & Spiess, J. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00027.x · Cited by 24
“…of animal models (Bale and Vale 2004; Lowry and Moore 2006; Valdez 2006), central nervous system concentration of CRF in human psychopathologies (Nemeroff et al. 1984; Banki et al. 1987; Nerozzi et al. 1988; Widerlov et al. 1988; Bremner et al. 1996; Heim et al. 1997; Arborelius et al. 1999;…”
BackgroundSavoy, C. D., Lieshout, R. J. V., & Steiner, M. S. (2016) · Acta Physiologica · doi:10.1111/apha.12726 · Cited by 25
Taguchi, R., Shikata, K., Furuya, Y., Hirakawa, T., Ino, M., Shin, K., & Shibata, H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.10.025 · Cited by 24
Friedmann, E., Son, H., & Tsai, C.-C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381453-1.10006-6 · Cited by 28
The neurobiology of stress and its relevance to psychotherapy
Gold, P. W. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.03.006 · Cited by 25
Dyck, B. P., Grigoriadis, D. E., Gross, R. S., Guo, Z., Haddach, M., Marinkovic, D., McCarthy, J. R., Moorjani, M., Regan, C. F., Saunders, J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050070m · Cited by 25
Psychiatry and Cardiovascular Disease
Schulman, J. K., Muskin, P. R., & Shapiro, P. A. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.2.208 · Cited by 28
Jensen, J. B., Mørk, A., & Mikkelsen, J. D. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00712.x · Cited by 24
Fibromyalgia Syndrome: Clinical Features, Diagnosis, and Biopathophysiologic Mechanisms
Yunus, M. B., & İnanıcı, F. (2002) · Elsevier eBooks · doi:10.1016/b978-0-323-01155-6.50007-4 · Cited by 32
Neuroendocrine dysfunction in depression: hypothalamic-anterior pituitary systems
Kalin, N. H., & Dawson, G. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90075-5 · Cited by 28
Kaye, W. H., Gendall, K. A., & Kye, C. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70011-3 · Cited by 29
Lesch, K., & Rupprecht, R. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258629 · Cited by 24
Mock, M. B., Zhang, S., Pakulski, K., Hutchison, C., Kapperman, M., Dreischarf, T., & Summers, R. M. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.11.005 · Cited by 23
Impact of sex and depressed mood on the central regulation of cardiac autonomic function
Garcia, R. G., Marečková, K., Holsen, L. M., Cohen, J. E., Whitfield, S., Napadow, V., Barbieri, R., & Goldstein, J. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0651-x · Cited by 25
Montgomery, K. R., Bridi, M. S., Folts, L. M., Marx-Rattner, R., Zierden, H. C., Wulff, A. B., Kodjo, E., Thompson, S. M., & Bale, T. L. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01739-5 · Cited by 25
Wada, T., Sameshima, A., Yonezawa, R., Morita, M., Sawakawa, K., Tsuneki, H., Sasaoka, T., & Saito, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209859 · Cited by 23
Traits of fear resistance and susceptibility in an advanced intercross line
McGuire, J. L., Bergstrom, H. C., Parker, C. C., Le, T., Morgan, M. A., Tang, H., Selwyn, R. G., Silva, A. C., Choi, K. H., Ursano, R. J., et al. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12337 · Cited by 25
“However, brain CRH levels are also associated with fear and anxiety (Kalin & Takahashi, 1990), PTSD (Baker et al., 1999), and depression (Nemeroff et al., 1984; Wang et al., 2009).”
Background
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.